In his past life, former NHL forward Bryan Bickell already would have begun preparing for next season by now. Unless, of course, it was one of three times he won the Stanley Cup with the Chicago Blackhawks, in which case he'd still be busy wrapping up the season. But more than two months after playing his final NHL game, Bickell has moved on to his next life. That brought him to New York on Thursday for a blitz of media interviews to share his story about living with relapsing-remitting multiple sclerosis. After that, he was scheduled to fly to Toronto to speak at an MS fundraising event there Thursday evening. "With this falling in my lap, I've been encouraged to do it more," Bickell said. "I think I was a guy who always did charity events and helped out in any way in different things. This just brings more things for me to do." In addition to having more time to spend with his wife, Amanda, and their two young daughters, Bickell views his retirement at age 31 as an opportunity to help educate others about MS, a disease of the central nervous system that he was diagnosed with Nov. 10 when he was playing for the Carolina Hurricanes. His goal? "A cure," he said. "And for me, and more than 2 million people in the world [with MS], to help in any way. … I'm working with Biogen to spread the word and my story and hopefully inspire a lot of other people." Biogen is the pharmaceutical company that manufactures Tysabri, the medication Bickell has been taking once a month since December to treat his MS. Before Bickell was diagnosed, he had been experiencing symptoms for a year and a half, including dizziness that initially was thought to be an ocular issue.